Loading...
OTCM
HLOC
Market cap312kUSD
Jul 09, Last price  
0.04USD
1Q
-93.51%
Jan 2017
-99.15%
IPO
-95.24%
Name

Helo Corp

Chart & Performance

D1W1MN
OTCM:HLOC chart
P/E
0.35
P/S
0.68
EPS
0.10
Div Yield, %
Shrs. gr., 5y
18.76%
Rev. gr., 5y
-1.98%
Revenues
5m
+372,853.64%
12,48219,80001,670,1282,272,2094,110,0005,031,6501,991,98217,204,87664,703,4461,2214,553,764
Net income
9m
P
-6,409-29,825-173,600-3,714,614-495,785-1,130,747-1,922,507-1,555,2041,323,37010,201,166-463,7318,783,435
CFO
-9m
L-19.91%
13,791-14,585-418,890-2,537,275-311,449-636,002-881,426-209,8573,752,24316,415,975-10,938,195-8,760,011

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Helo Corp. operates as a wellness technology firm, primarily focused on the "quantified-self" market through its range of wearable devices. These devices, along with their accompanying applications, enable users to gain health insights by meticulously tracking their personal data. Among its offerings is the VYVO Vista, which gathers information for analyzing resting and active heart rates, estimating blood pressure, monitoring breath rate and energy levels, and providing feedback on mood and sleep quality. The product line also features the VYVO Sense, a smartband equipped with 6-axis movement detection and an integrated electrocardiogram (ECG) sensor. For more in-depth monitoring, the company offers the VYVO Icon smartwatch. This device collects data that allows third parties to estimate parameters such as body fat percentage, visceral fat levels, muscle mass, and bone mass. It can also generate third-party representations of ECGs and continuously detect potential irregular heart rhythms, including atrial fibrillation (AFib) and other arrhythmias. Beyond wearables, Helo Corp. provides the VYVO Leggera, a smart weighing scale that measures body weight and incorporates a bio-impedance (BI) sensor to infer bone weight, visceral fat, and body mass index. Further extending its collection are the VYVO Vista+ and the VYVO Watch Lite, which boasts capabilities such as continuous AFib detection, mood and energy tracking, fall detection, SpO2 (blood oxygen) measurement, and sleep apnea detection. The VYVO Watch Lite SE builds on this with highly accurate body temperature readings, precise to ±0.1°C. Its advanced offering, the VYVO Watch Generation 2, delivers medical-grade measurements with enhanced accuracy for blood oxygen levels, vascular aging assessments, and ECGs. Helo Corp. distributes its products through a strategic partnership with VYVO HK Ltd. and its established global distribution network. The company, headquartered in San Francisco, California, was founded in 2010. It originally operated under the name World Technology Corp. before rebranding to Helo Corp. in October 2018.
IPO date
May 13, 2014
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT